Target General Infomation
Target ID
T00938
Former ID
TTDI02203
Target Name
DHICA oxidase
Gene Name
TYRP1
Synonyms
5,6dihydroxyindole2carboxylic acid oxidase; Catalase B; Glycoprotein 75; Melanoma antigen gp75; TRP; TRP1; Tyrosinaserelated protein 1; TYRP1
Target Type
Clinical Trial
Disease Melanoma [ICD9: 172; ICD10: C43]
Function
Oxidation of 5,6-dihydroxyindole-2-carboxylic acid (DHICA)into indole-5,6-quinone-2-carboxylic acid. May regulate or influence the type of melanin synthesized.
BioChemical Class
Tyrosinase
UniProt ID
EC Number
EC 1.14.18.-
Sequence
MSAPKLLSLGCIFFPLLLFQQARAQFPRQCATVEALRSGMCCPDLSPVSGPGTDRCGSSS
GRGRCEAVTADSRPHSPQYPHDGRDDREVWPLRFFNRTCHCNGNFSGHNCGTCRPGWRGA
ACDQRVLIVRRNLLDLSKEEKNHFVRALDMAKRTTHPLFVIATRRSEEILGPDGNTPQFE
NISIYNYFVWTHYYSVKKTFLGVGQESFGEVDFSHEGPAFLTWHRYHLLRLEKDMQEMLQ
EPSFSLPYWNFATGKNVCDICTDDLMGSRSNFDSTLISPNSVFSQWRVVCDSLEDYDTLG
TLCNSTEDGPIRRNPAGNVARPMVQRLPEPQDVAQCLEVGLFDTPPFYSNSTNSFRNTVE
GYSDPTGKYDPAVRSLHNLAHLFLNGTGGQTHLSPNDPIFVLLHTFTDAVFDEWLRRYNA
DISTFPLENAPIGHNRQYNMVPFWPPVTNTEMFVTAPDNLGYTYEIQWPSREFSVPEIIA
IAVVGALLLVALIFGTASYLIRARRSMDEANQPLLTDQYQCYAEEYEKLQNPNQSVV
Drugs and Mode of Action
Drug(s) Flanvotumab Drug Info Phase 1 Melanoma [523062]
Target Expression Profile (TEP) and Drug Resistance Mutation (DRM)
TEP EXP Info
Pathways
BioCyc Pathway Eumelanin biosynthesis
KEGG Pathway Tyrosine metabolism
Metabolic pathways
Melanogenesis
Pathway Interaction Database Direct p53 effectors
PathWhiz Pathway Degradation of Superoxides
References
Ref 523062ClinicalTrials.gov (NCT01137006) An Open-Label, Dose-Escalation Study of IMC-20D7S In Patients With Malignant Melanoma. U.S. National Institutes of Health.
Ref 550460National Cancer Institute Drug Dictionary (drug id 675217).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.